Stifel Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
16,316
-2,630
| -14% | -$94.8K | ﹤0.01% | 2679 |
|
|
2025
Q1 | $590K | Buy |
18,946
+1,794
| +10% | +$55.8K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $438K | Sell |
17,152
-2,200
| -11% | -$56.1K | ﹤0.01% | 2755 |
|
|
2024
Q3 | $547K | Sell |
19,352
-530
| -3% | -$15K | ﹤0.01% | 2626 |
|
|
2024
Q2 | $524K | Buy |
19,882
+12,095
| +155% | +$319K | ﹤0.01% | 2594 |
|
|
2024
Q1 | $236K | Buy |
+7,787
| New | +$236K | ﹤0.01% | 3027 |
|
|
2023
Q3 | – | Sell |
-9,692
| Closed | -$298K | – | 3389 |
|
|
2023
Q2 | $298K | Buy |
9,692
+3,464
| +56% | +$106K | ﹤0.01% | 2826 |
|
|
2023
Q1 | $224K | Buy |
+6,228
| New | +$224K | ﹤0.01% | 2982 |
|
|
2022
Q4 | – | Sell |
-56,268
| Closed | -$2.26M | – | 3369 |
|
|
2022
Q3 | $2.26M | Buy |
56,268
+3,019
| +6% | +$121K | ﹤0.01% | 1384 |
|
|
2022
Q2 | $2.24M | Buy |
53,249
+44,829
| +532% | +$1.88M | ﹤0.01% | 1427 |
|
|
2022
Q1 | $329K | Sell |
8,420
-3,621
| -30% | -$141K | ﹤0.01% | 2826 |
|
|
2021
Q4 | $480K | Buy |
12,041
+6,495
| +117% | +$259K | ﹤0.01% | 2609 |
|
|
2021
Q3 | $201K | Buy |
5,546
+225
| +4% | +$8.16K | ﹤0.01% | 3132 |
|
|
2021
Q2 | $218K | Sell |
5,321
-55
| -1% | -$2.25K | ﹤0.01% | 3100 |
|
|
2021
Q1 | $235K | Buy |
+5,376
| New | +$235K | ﹤0.01% | 2932 |
|